Delivery of ENaC siRNA to epithelial cells mediated by a targeted nanocomplex: A therapeutic strategy for cystic fibrosis

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Manunta, Maria D I ^a   Tagalakis, Aristides D ^a   Attwood, Martin ^a,c   Aldossary, Ahmad M ^a   Barnes, Josephine L ^b   Munye, Mustafa M ^a   Weng, Alexander ^a,d   McAnulty, Robin J ^b   Hart, Stephen L ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EPITHELIAL SODIUM CHANNEL; LIPOSOME; NANOPARTICLE; PEPTIDE; SMALL INTERFERING RNA;

CELL CULTURE; CELL LINE; CHEMISTRY; CONFOCAL MICROSCOPY; CYSTIC FIBROSIS; EPITHELIUM CELL; GENE KNOCKDOWN; GENE SILENCING; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; GENETICS; METABOLISM; RNA INTERFERENCE;

CELL LINE; CELLS, CULTURED; CYSTIC FIBROSIS; EPITHELIAL CELLS; EPITHELIAL SODIUM CHANNELS; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; LIPOSOMES; MICROSCOPY, CONFOCAL; NANOPARTICLES; PEPTIDES; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSDUCTION, GENETIC; TRANSFECTION;

EID: 85018789132     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-00662-2     Document Type: Article

References (36)

1. Riordan, J. R., et al. Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA. Science 245, 1066-1073 (1989).
2. Buchwald, M., Tsui, L. C., Riordan, J. R. The search for the cystic fibrosis gene. American Journal of Physiology 257, L47-52 (1989).
3. Mall, M. A., Galietta, L. J. Targeting ion channels in cystic fibrosis. Journal of Cystic Fibrosis 14, 561-570 (2015).
4. Canessa, C. M., et al. Amiloride-sensitive epithelial Na+ channel is made of three homologous subunits. Nature 367, 463-467 (1994).
5. Rossier, B. C., Canessa, C. M., Schild, L., Horisberger, J. D. Epithelial sodium channels. Current Opinion in Nephrology andHypertension 3, 487-496 (1994).
6. Stockand, J. D., Staruschenko, A., Pochynyuk, O., Booth, R. E., Silverthorn, D. U. Insight toward epithelial Na+ channel mechanismrevealed by the acid-sensing ion channel 1 structure. IUBMB Life 60, 620-628 (2008).
7. Edelheit, O., Hanukoglu, I., Dascal, N., Hanukoglu, A. Identification of the roles of conserved charged residues in the extracellulardomain of an epithelial sodium channel (ENaC) subunit by alanine mutagenesis. American Journal of Physiology 300, F887-897(2011).
8. Hanukoglu, I., Hanukoglu, A. Epithelial sodium channel (ENaC) family: Phylogeny, structure-function, tissue distribution, associated inherited diseases. Gene 579, 95-132 (2016).
9. Giraldez, T., et al. Cloning and functional expression of a new epithelial sodium channel delta subunit isoform differentiallyexpressed in neurons of the human and monkey telencephalon. Journal of Neurochemistry 102, 1304-1315 (2007).
10. Haerteis, S., Krueger, B., Korbmacher, C., Rauh, R. The delta-subunit of the epithelial sodium channel (ENaC) enhances channelactivity and alters proteolytic ENaC activation. Journal of Biological Chemistry 284, 29024-29040 (2009).
11. Barker, P. M., et al. Role of gammaENaC subunit in lung liquid clearance and electrolyte balance in newborn mice. Insights intoperinatal adaptation and pseudohypoaldosteronism. Journal of Clinical Investigation 102, 1634-1640 (1998).
12. Rossier, B. C. Hormonal regulation of the epithelial sodium channel ENaC: N or P(o) Journal of General Physiology 120, 67-70(2002).
13. Butler, R., Hunt, T., Smith, N. J. ENaC inhibitors for the treatment of cystic fibrosis. Pharmaceutical Patent Analyst 4, 17-27 (2015).
14. Elbashir, S. M., et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494-498(2001).
15. Harborth, J., Elbashir, S. M., Bechert, K., Tuschl, T., Weber, K. Identification of essential genes in cultured mammalian cells usingsmall interfering RNAs. Journal of Cell Science 114, 4557-4565 (2001).
16. Writer, M. J., et al. Targeted gene delivery to human airway epithelial cells with synthetic vectors incorporating novel targetingpeptides selected by phage display. Journal of Drug Targeting 12, 185-193 (2004).
17. Irvine, S. A., et al. Receptor-targeted nanocomplexes optimized for gene transfer to primary vascular cells and explant cultures ofrabbit aorta. Molecular Therapy 16, 508-515 (2008).
18. Tagalakis, A. D., He, L., Saraiva, L., Gustafsson, K. T., Hart, S. L. Receptor-targeted liposome-peptide nanocomplexes for siRNAdelivery. Biomaterials 32, 6302-6315 (2011).
19. Manunta, M. D., et al. Nebulisation of Receptor-Targeted Nanocomplexes for Gene Delivery to the Airway Epithelium. PloS one 6, e26768 (2011).
20. Tagalakis, A. D., et al. Multifunctional, self-assembling anionic peptide-lipid nanocomplexes for targeted siRNA delivery.Biomaterials 35, 8406-8415 (2014).
21. Weng, A., et al. Improved intracellular delivery of peptide-A nd lipid-nanoplexes by natural glycosides. Journal of Controlled Release206, 75-90 (2015).
22. Manunta, M. D., et al. Airway Deposition of Nebulized Gene Delivery Nanocomplexes Monitored by Radioimaging Agents.American Journal of Respiratory Cell and Molecular Biology 49, 471-480 (2013).
23. O'Callaghan, C., Barry, P. W. The science of nebulised drug delivery. Thorax 52, S31-44 (1997).
24. Yu-Wai-Man, C., Tagalakis, A. D., Manunta, M. D., Hart, S. L., Khaw, P. T. Receptor-targeted liposome-peptide-siRNAnanoparticles represent an efficient delivery system for MRTF silencing in conjunctival fibrosis. Scientific Reports 6, 21881 (2016).
25. Tagalakis, A. D., Saraiva, L., McCarthy, D., Gustafsson, K. T., Hart, S. L. Comparison of nanocomplexes with branched and linearpeptides for siRNA delivery. Biomacromolecules 14, 761-770 (2013).
26. Tagalakis, A. D., et al. A method for concentrating lipid peptide DNA and siRNA nanocomplexes that retains their structure andtransfection efficiency. International Journal of Nanomedicine 10, 2673-2683 (2015).
27. Prince, L. S., Welsh, M. J. Cell surface expression and biosynthesis of epithelial Na+ channels. Biochemical Journal 336, 705-710(1998).
28. Tucker, J. K., et al. Cloning and functional studies of splice variants of the alpha-subunit of the amiloride-sensitive Na+ channel.American Journal of Physiology 274, C1081-1089 (1998).
29. Ruffieux-Daidié, D., Staub, O. Intracellular ubiquitylation of the epithelial Na+ channel controls extracellular proteolytic channelactivation via conformational change. Journal of Biological Chemistry 286, 2416-2424 (2011).
30. Knight, K. K., Olson, D. R., Zhou, R., Snyder, P. M. Liddle's syndrome mutations increase Na+ transport through dual effects onepithelial Na+ channel surface expression and proteolytic cleavage. Proc Natl Acad Sci USA 103, 2805-2808 (2006).
31. Kabra, R., Knight, K. K., Zhou, R., Snyder, P. M. Nedd4-2 induces endocytosis and degradation of proteolytically cleaved epithelialNa+ channels. Journal of Biological Chemistry 283, 6033-6039 (2008).
32. Hummler, E., et al. Early death due to defective neonatal lung liquid clearance in alpha-ENaC-deficient mice. Nature Genetics 12, 325-328 (1996).
33. Fulcher, M. L., et al. Novel human bronchial epithelial cell lines for cystic fibrosis research. American Journal of Physiology 296, L82-91 (2009).
34. Munye, M. M., Shoemark, A., Hirst, R. A., et al. BMI-1 extends proliferative potential of human bronchial epithelial cells whileretaining their mucociliary differentiation capacity. American Journal of Physiology 312, L258-L267 (2017).
35. Tagalakis, A. D., et al. A receptor-targeted nanocomplex vector system optimized for respiratory gene transfer. Molecular Therapy 16, 907-915 (2008).
36. Reinhardt, A. K., Bottoms, S. E., Laurent, G. J., McAnulty, R. J. Quantification of collagen and proteoglycan deposition in a murinemodel of airway remodelling. Respiratory Research 6, 30 (2005).